Health Physics Division, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Radiation Oncology Division, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
J Appl Clin Med Phys. 2023 Aug;24(8):e13982. doi: 10.1002/acm2.13982. Epub 2023 Jul 3.
A system for stabilizing and monitoring eye movements during LINAC-based photon beam one single fraction stereotactic radiotherapy was developed at our Institution. This study aimed to describe the feasibility and the efficacy of our noninvasive optical localization system that was developed, tested, and applied in 20 patients treated for uveal melanoma.
Our system consisted of a customized thermoplastic mask to immobilize the head, a gaze fixation LED, and a digital micro-camera. The localization procedure, which required the active collaboration of the patient, served to monitor the eye movements during all phases of the treatment, starting from the planning computed tomography up to the administration of radiotherapy, and allowed the operators to suspend the procedure and to interact with the patient in case of large movements of the pupil.
Twenty patients were treated with stereotactic radiosurgery (27 Gy in one fraction) for primary uveal melanoma. All patients showed a good tolerance to the treatment; until now, all patients were in local control during the follow up and one died for distant progression 6 months after radiosurgery.
This study showed that this noninvasive technique, based on eye position control, is appropriate and can contribute to the success of LINAC-based stereotactic radiotherapy. A millimetric safety margin to the clinical target volume was adequate to take account for the organ movement. All patients treated till now showed a good local control; failures in the disease control were due to metastatic spread.
在我们机构开发了一种用于在基于 LINAC 的光子束单次分割立体定向放射治疗中稳定和监测眼球运动的系统。本研究旨在描述我们开发、测试和应用于 20 例治疗脉络膜黑色素瘤患者的非侵入性光学定位系统的可行性和疗效。
我们的系统包括一个定制的热塑面罩来固定头部、一个注视固定 LED 和一个数字微相机。定位过程需要患者的积极配合,用于监测治疗过程中的所有阶段的眼球运动,从计划 CT 到放射治疗的实施,并允许操作人员在瞳孔出现大幅度运动时暂停程序并与患者进行交互。
20 例原发性脉络膜黑色素瘤患者接受立体定向放射外科治疗(27Gy 单次分割)。所有患者均对治疗有良好的耐受性;到目前为止,所有患者在随访期间均处于局部控制状态,1 例患者在放射外科治疗后 6 个月因远处进展而死亡。
本研究表明,这种基于眼球位置控制的非侵入性技术是合适的,可以有助于基于 LINAC 的立体定向放射治疗的成功。到临床靶体积的毫米级安全边界足以考虑器官运动。到目前为止,所有接受治疗的患者均显示出良好的局部控制;疾病控制的失败是由于转移扩散。